Inch, JacquelineNotman, FrancesBond, ChristineAlldred, David P.Arthur, AntonyBlyth, AnnieDaffu-O'Reilly, AmritFord, JoannaHughes, Carmel M.Maskrey, VivienneMillar, AnnaMyint, Phyo K.Poland, Fiona M.Shepstone, LeeZermansky, ArnoldHolland, RichardWright, DavidCHIPPS Team2019-07-152019-07-152019-07-11Inch, J, Notman, F, Bond, C, Alldred, D P, Arthur, A, Blyth, A, Daffu-O'Reilly, A, Ford, J, Hughes, C M, Maskrey, V, Millar, A, Myint, P K, Poland, F M, Shepstone, L, Zermansky, A, Holland, R, Wright, D & CHIPPS Team 2019, 'The Care Home Independent Prescribing Pharmacist Study (CHIPPS) : A non-randomised feasibility study of independent pharmacist prescribing in care homes', Pilot & Feasibility Studies, vol. 5, 89. https://doi.org/10.1186/s40814-019-0465-y2055-5784PubMedCentral: PMC6625047Mendeley: b44a4e30-877b-323c-9e17-1d12e7c39403ORCID: /0000-0003-3852-6158/work/163198601http://hdl.handle.net/2164/12565Acknowledgements We also thank Lisa Irvine who contributed to data analysis. We thank PPIRes (Public and Patient Involvement in Research) for being formal collaborators on the grant and for advice on ongoing conduct of the study as represented by Kate Massey (sadly deceased) and Christine Handford. We thank Helen Hill who is a grant holder with Care Home background and who advised on ongoing conduct of the study, and Ian Small, the lead primary care medicines management pharmacist in Norwich (now retired) and a co-applicant on the NIHR programme grant. On behalf of the CHIPPS Team, we would also like to acknowledge Antony Colles, Norwich Clinical Trials Unit, Norwich Medical School, Faculty of Medicine and Health Sciences and the NHS South Norfolk Clinical Commissioning Group (CCG) as the study sponsor and host of PPIRes, and especially Clare Symms, Norfolk & Suffolk Primary and Community Care Research Office, for her contribution towards the study. Finally, we wish to thank all the participants in this study from general practices and care homes. Registration information The trial was registered on the ISRCTN registry, registration number ISRCTN10663852. The study was overseen by a Programme Management Group (all grant holders, researchers, CTU representatives) and advised by an independent Trial Steering Committee. The protocol is available from the authors on request. Funding This paper reports independent research funded by the National Institute for Health Research (Programme Grants for Applied Research, Care Homes Independent Pharmacist Prescribing Service (CHIPPS): Development and delivery of a cluster randomised controlled trial to determine both its effectiveness and cost-effectiveness, RP-PG-0613-20007). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.141563284engRS Pharmacy and materia medicaNational Institute for Health Research (NIHR)RP-PG-0613-20007Supplementary DataRSJournal article10.1186/s40814-019-0465-yhttps://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-019-0465-yhttp://www.mendeley.com/research/care-home-independent-prescribing-pharmacist-study-chippsa-nonrandomised-feasibility-study-independe5